Compound Screening, Fragment Screening and Small Molecule

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Compound Screening

Fragment Screening

Small Molecule

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. In terms of compound libraries, we have a high-throughput screening library of about 200,000 ligands.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

Open-source Electrophilic Fragment Screening Platform to Identify Chemical Starting Points for UCHL1 Covalent Inhibitors

Covalent Modifiers

DECEMBER 3, 2024

Marto SLAS Discovery, 2024 [link] Target-based screening of covalent fragment libraries with mass spectrometry has emerged as a powerful strategy to identify chemical starting points for small molecule inhibitors or find new binding pockets on proteins of interest.

Fragment Screening

Fragment Screening Compound Screening Small Molecule Drugs

Drug Discovery Digest

Target-directed cancer: protein-ligand interactions

Open-source Electrophilic Fragment Screening Platform to Identify Chemical Starting Points for UCHL1 Covalent Inhibitors

Stay Connected